Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years
- Author
- DOMINICUS, Rolf1 ; GALTIER, Florence2 3 ; RICHARD, Patrick4 ; BAUDIN, Martine4
[1] Hautzentrum Dulmen, Praxisklinik Doctor Bockhorst/Doctor Dominicus, Vollenstrasse 8, 48249 Dülmen, Germany
[2] National Network of Clinical Investigation in Vaccinology (REIVAC), Institut National de la Santé et de la Recherche Médicale (INSERM), France
[3] Centre d'Investigation Clinique (CIC), INSERM, CHRU Montpellier Hôpital Saint-Eloi 80, av. Augustin Fliche, 34295 Montpellier, France
[4] Sanofi Pasteur MSD, 162, avenue Jean Jaurès, CS 50712, 69367 Lyon, France - Source
Vaccine. 2014, Vol 32, Num 31, pp 3942-3949, 8 p ; ref : 26 ref
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Boosters Immunogenicity Safety Seroprotection Td-IPV Tdap-IPV
- Keyword (fr)
- Diphtérie Immunogénicité Poliomyélite antérieure Rappel vaccination Tétanos Vaccin acellulaire Vaccin associé Vaccination Bactériose Infection Pathologie de la moelle épinière Pathologie du système nerveux central Pathologie du système nerveux Virose
- Keyword (en)
- Diphtheria Immunogenicity Acute anterior poliomyelitis Booster vaccination Tetanus Acellular vaccine Mixed vaccine Vaccination Bacteriosis Infection Spinal cord disease Central nervous system disease Nervous system diseases Viral disease
- Keyword (es)
- Difteria Inmunogenicidad Poliomielitis anterior Vacunación de refuerzo Tetanos Vacuna acelular Vacuna mixta Vacunación Bacteriosis Infección Médula espinal patología Sistema nervosio central patología Sistema nervioso patología Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05B Bacterial diseases / 002B05B02 Human bacterial diseases / 002B05B02B Ent and stomatologic bacterial diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02A Viral diseases of the nervous system
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28528768
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.vaccine.2014.05.034 
https://dx.doi.org/10.1016/j.vaccine.2014.05.034
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:2:\"31\";s:8:\"\u0000*\u0000spage\";s:4:\"3942\";s:8:\"\u0000*\u0000epage\";s:4:\"3949\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DOMINICUS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Rolf\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:17:\"GALTIER, Florence\";i:1;s:16:\"RICHARD, Patrick\";i:2;s:15:\"BAUDIN, Martine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:2:\"31\";s:8:\"\u0000*\u0000spage\";s:4:\"3942\";s:8:\"\u0000*\u0000epage\";s:4:\"3949\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DOMINICUS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Rolf\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:17:\"GALTIER, Florence\";i:1;s:16:\"RICHARD, Patrick\";i:2;s:15:\"BAUDIN, Martine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:2:\"31\";s:8:\"\u0000*\u0000spage\";s:4:\"3942\";s:8:\"\u0000*\u0000epage\";s:4:\"3949\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DOMINICUS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Rolf\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:17:\"GALTIER, Florence\";i:1;s:16:\"RICHARD, Patrick\";i:2;s:15:\"BAUDIN, Martine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:2:\"31\";s:8:\"\u0000*\u0000spage\";s:4:\"3942\";s:8:\"\u0000*\u0000epage\";s:4:\"3949\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DOMINICUS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Rolf\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:17:\"GALTIER, Florence\";i:1;s:16:\"RICHARD, Patrick\";i:2;s:15:\"BAUDIN, Martine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2014.05.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:2:\"31\";s:8:\"\u0000*\u0000spage\";s:4:\"3942\";s:8:\"\u0000*\u0000epage\";s:4:\"3949\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DOMINICUS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Rolf\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:17:\"GALTIER, Florence\";i:1;s:16:\"RICHARD, Patrick\";i:2;s:15:\"BAUDIN, Martine\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:313:\"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
